Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory

Eylem Tunçay1, Özlem Moçin2, Özlem Ediboğdu3

  • 1Department of Intensive Care, University of Medical Sciences Şehit Prof. Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkey.

PubMed

Insights

Long-COVID patients admitted to the intensive care unit (ICU) often present with pneumonia, comorbidities, and high severity scores. These factors, along with corticosteroid use and extensive lung involvement, may contribute to frequent ICU readmissions.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Coronavirus disease 2019 (COVID-19) has caused significant global morbidity and mortality.
  • Long-COVID, characterized by subacute and long-term effects, contributes to ongoing health burdens.
  • Intensive care unit (ICU) data provides crucial insights into severe COVID-19 outcomes.

Purpose of the Study:

  • To evaluate intensive care unit (ICU) data from patients diagnosed with long-COVID.
  • To identify characteristics and outcomes of long-COVID patients requiring critical care.
  • To understand factors associated with severe disease in long-COVID survivors.

Main Methods:

  • A multicenter point prevalence study involving 11 centers.
  • Inclusion of patients diagnosed with long-COVID and managed in the ICU.
  • Analysis of demographic, clinical, and radiological data.

Main Results:

  • 41 long-COVID patients (mean age 66±14, 50% male) were analyzed.
  • High rates of comorbidities (hypertension 27%, diabetes 51%) and malignancies (34%) were observed.
  • Moderate hypoxemic respiratory failure, high severity scores (APACHE II 18, SOFA 6), and significant rates of mechanical ventilation (46%) and sepsis (42%) were noted.
  • Chest imaging revealed bilateral (67%) and interstitial (37%) involvement, with 27% showing fibrosis.
  • 71% received broad-spectrum antibiotics, and 61% received corticosteroid treatment.

Conclusions:

  • A significant proportion of ICU patients with long-COVID had pneumonia and required broad-spectrum antibiotics.
  • High rates of comorbidities, malignancies, severe illness scores, intubation, and sepsis were identified.
  • Corticosteroid treatment and extensive bilateral lung involvement may be associated with high ICU readmission rates for long-COVID patients.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
167
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
184
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
133
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
192
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
314